Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Jul;8(1):45–49. doi: 10.1128/aac.8.1.45

Diffusion of Trimethoprim and Sulfamethoxazole from Susceptibility Disks into Agar Medium

M E Grace 1, S R M Bushby 1, C W Sigel 1
PMCID: PMC429258  PMID: 1099981

Abstract

The standard practice of using a single susceptibility disk for the antimicrobial combination Septra (trimethoprim/sulfamethoxazole) has been further justified by a direct measurement of the diffusion rates of each compound through agar medium. [14C]trimethoprim and [35S]sulfamethoxazole, singly and in combination, were applied to blank susceptibility disks which were incubated on 4-inch (10.16-cm) agar plates (Mueller-Hinton medium) at 37 C. The migration of each compound from the disk and diffusion through agar were measured with time by determining the radioactivity in concentric zones extending from the origin. The two compounds diffuse with similar rates, maintaining approximately a 1:20 concentration ratio which is approximately the ratio of trimethoprim to sulfamethoxazole observed in plasma during treatment. The diffusion rate is independent of the presence of the other compound; greater than 95% of the radioactivity is transferred from the disk to the agar in 24 h.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. C., Finland M., Gold O., Wilcox C. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined. J Infect Dis. 1973 Nov;128(Suppl):508–p. doi: 10.1093/infdis/128.supplement_3.s508. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Bushby S. R. Sensitivity testing with trimethorpim-sulphamethoxazole. Med J Aust. 1973 Jun 30;1(2 Suppl):10–18. [PubMed] [Google Scholar]
  4. Bushby S. R. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. J Infect Dis. 1973 Nov;128(Suppl):442–p. doi: 10.1093/infdis/128.supplement_3.s442. [DOI] [PubMed] [Google Scholar]
  5. Dornbusch K. Regression line analysis of the synergistic effect for the combination of trimethoprim-sulphamethoxazole. Chemotherapy. 1971;16(4):229–238. doi: 10.1159/000220731. [DOI] [PubMed] [Google Scholar]
  6. Hitchings G. H., Burchall J. J. Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv Enzymol Relat Areas Mol Biol. 1965;27:417–468. doi: 10.1002/9780470122723.ch9. [DOI] [PubMed] [Google Scholar]
  7. Hitchings G. H. Mechanism of action of trimethoprim-sulfamethoxazole. I. J Infect Dis. 1973 Nov;128(Suppl):433–p. doi: 10.1093/infdis/128.supplement_3.s433. [DOI] [PubMed] [Google Scholar]
  8. Kayser F. H., Wüst J. Determination of bacterial resistance to trimethoprim-sulphamethoxazole using the single disc diffusion method. Chemotherapy. 1973;18(3):162–168. doi: 10.1159/000221258. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES